Viatris was formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, we aim to deliver affordable and quality medicines for patients worldwide.
Our global portfolio includes best-in-class, iconic brand name products as well as global key brands; generics, including branded and complex generics; and over-the-counter offerings across a wide range of therapeutic areas. We are committed to helping create healthier communities worldwide through education, outreach, and better access to treatment.
At Viatris, we see healthcare not as it is but as it should be. We act courageously and are uniquely positioned to be a source of stability in a world of evolving healthcare needs.
Providing reliable
medicines everywhere
for everyone
Driving innovation
and sustainable
solutions
Connecting people,
products, and services to
improve patient health
It’s all about good health, everywhere for everyone!
Viatris believes that health is the single most important thing for any individual and that in every living being there is a power to heal and stay healthy.
Viatris aims to deliver the access to medicine, trusted partner for healthcare communities and provider of innovative solutions to improve patient health.
Together we will make the world healthier through oneness and care.
HEAL... Is an educational campaign of Viatris Medical Affairs
For more information visit Viatris Connect Medical.
